A Study To Evaluate The Mechanism Of Action Of CP-690,550 In Patients With Rheumatoid Arthritis



Status:Archived
Conditions:Arthritis, Rheumatoid Arthritis
Therapuetic Areas:Rheumatology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:November 2009
End Date:November 2011

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

An Exploratory Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Pharmacodynamics Of CP-690,550, Administered Orally Twice Daily (BID) For 4 Weeks, In Subjects With Active Rheumatoid Arthritis


To explore the effect of CP-690,550 on blood and synovial markers in subjects with
rheumatoid arthritis. To evaluate the safety, tolerability and efficacy of CP-690,550.



We found this trial at
7
sites
Pfizer Investigational Site
Los Angeles, California 90027
1982
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Pfizer Investigational Site
Akron, Ohio 44314
106
mi
from 43215
Akron, OH
Click here to add this to my saved trials
Pfizer Investigational Site
Alabaster, Alabama 35007
510
mi
from 43215
Alabaster, AL
Click here to add this to my saved trials
Maine Research Associates
Auburn, Maine 04210
714
mi
from 43215
Auburn, ME
Click here to add this to my saved trials
Pfizer Investigational Site
Baltimore, Maryland 21234
346
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Pfizer Investigational Site
Houston, Texas 77030
995
mi
from 43215
Houston, TX
Click here to add this to my saved trials
Pfizer Investigational Site
Seattle, Washington 98166
2007
mi
from 43215
Seattle, WA
Click here to add this to my saved trials